Share

The key list

Powered by

Leading generics companies in China and Hong Kong by revenue

This month our pharma industry key list brings you the 15 largest companies in China and Hong Kong by revenue, as ranked by GlobalData's Pharma Intelligence Centre. All numbers as of July 2020.

Company nameAnnual revenue ($million)Headquarters locationNumber of employees

China Resources Pharmaceutical Group Ltd

24,204Hong Kong66,000

Shanghai Pharmaceutical Co Ltd

24,050China47,620

Nanjing Pharmaceutical Co Ltd

4,732China5,000

Huadong Medicine Co Ltd

4,636China-

Shanghai Fosun Pharmaceutical (Group) Co Ltd

3,767China28,245

Sino Biopharmaceutical Ltd

3,158Hong Kong23,475

CSPC Pharmaceutical Group Ltd

2,797China14,471

Tasly Pharmaceutical Group Co Ltd

2,720China9,235

Cachet Pharmaceutical Co Ltd

2,715China2,713

Jiangsu Hengrui Medicine Co Ltd

2,633China24,700

Sichuan Kelun Pharmaceutical Co Ltd

2,472China19,990

Harbin Pharmaceutical Group Co Ltd

1,635China14,295

Zhejiang Hisun Pharmaceutical Co Ltd

1,540China9,871

North China Pharmaceutical Co Ltd

1,393China10,909

Livzon Pharmaceutical Group Co Ltd

1,340China7,671

Share this article

Go to article: Home | The Route to RecoveryGo to article: In this issueGo to article: MimotopesGo to article: ContentsGo to article: NewsGo to article: VEGA Company Insight Go to article: VEGA AustraliaGo to article: Covid-19 executive briefing by GlobalDataGo to article: Identifying a viable Covid-19 vaccine candidate and steps needed for its successful implementationGo to article: Impact of Covid-19 on patients with hepatocellular carcinomaGo to article: NSFGo to article: Novavax to receive $1.6B from Operation Warp Speed for the development of Covid-Go to article: FDA winners and losers in Covid-19 therapiesGo to article: Pfeiffer VacuumGo to article: Trials delayed due to Covid-19 begin to resumeGo to article: ILC Dover Go to article: The pharma industry briefingGo to article: From rare diseases to Covid-19: charting the history of Genomics EnglandGo to article: Covid-19: how will pharma cope with a looming recession?Go to article: Pandemic logistics: guaranteeing equitable accessGo to article: Pandemic logistics: Resolving manufacturing and distribution challengesGo to article: KugelmeiersGo to article: Q&A: how to find the right clinical trial participants with Innovative TrialsGo to article: Recce Pharma: a new frontier in the fight against AMRGo to article: Autism pipeline: are better therapies in sight?Go to article: How a new crystallography technique may speed up drug developmentGo to article: Psychedelics: a game-changer in mental health? Go to article: Graph technology: the remedy for broken supply chains is connected dataGo to article: Deals in brief powered by GlobalDataGo to article: The key list powered by GlobalDataGo to article: Global markets and indices powered by GlobalDataGo to article: Macro-economic indicators (1 of 2) powered by GlobalDataGo to article: Macro-economic indicators (2 of 2) powered by GlobalDataGo to article: EventsGo to article: Next issue